Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation

Antiviral therapy for recurrent hepatitis C in liver transplant recipients has been associated with low efficacy, poor tolerability, and drug-drug interactions. Recent approval of various hepatitis C direct-acting antivirals has resulted in improvement of these parameters. We evaluated the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Khemichian, Saro, Lee, Brian, Kahn, Jeffrey, Noureddin, Mazen, Kim, Brian, Harper, Tammy, Esmailian, Yvonne, Fong, Tse-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946469/
https://www.ncbi.nlm.nih.gov/pubmed/27500223
http://dx.doi.org/10.1097/TXD.0000000000000531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946469/
https://www.ncbi.nlm.nih.gov/pubmed/27500223
http://dx.doi.org/10.1097/TXD.0000000000000531

Ejemplares similares